Thymosin α1: a single drug with multiple targets in cystic fibrosis

Nature Medicine 23, 536 (2017). doi:10.1038/nm.4339 Authors: André M Cantin & John W Hanrahan A new study in mice suggests that a single drug, thymosin α1, may simultaneously rectify the impaired trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis (CF) and reduce inflammation, offering new hope for CF treatment.
Source: Nature Medicine - Category: Journals (General) Authors: Tags: News and Views Source Type: research